Who is sponsoring NCT02860858?

NCT02860858 is sponsored by Department of Medical Services Ministry of Public Health of Thailand.

What drugs are being tested in NCT02860858?

Interventions in NCT02860858: Intravitreous aflibercept injection.

What condition does NCT02860858 study?

NCT02860858 studies Symtomatic Macular Polypoidal Choroidal Vasculopathy.

Is NCT02860858 still recruiting?

NCT02860858 is currently completed. Last updated 23 October 2020.

Last reviewed 2020-10-23 · How we verify

NCT02860858

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Intravitreal Aflibercept for Treatment of Polypoidal Choroidal Vasculopathy (PCV)

Completed Phase 4 Last updated 23 October 2020

What this trial tests

Phase 4 trial testing Intravitreous aflibercept injection in Symtomatic Macular Polypoidal Choroidal Vasculopathy in 50 participants. Completed in 31 December 2018.

Timeline

30 December 2016

Primary endpoint
30 August 2018

31 December 2018

Quick facts

Lead sponsor	Department of Medical Services Ministry of Public Health of Thailand
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	50
Start date	30 December 2016
Primary completion	30 August 2018
Estimated completion	31 December 2018
Sites	1 location across Thailand

Drugs / interventions tested

Intravitreous aflibercept injection

Conditions studied

Symtomatic Macular Polypoidal Choroidal Vasculopathy — all drugs for Symtomatic Macular Polypoidal Choroidal Vasculopathy →

Sponsor

Department of Medical Services Ministry of Public Health of Thailand

Who can join

18 and older, any sex, with Symtomatic Macular Polypoidal Choroidal Vasculopathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Objective: To evaluate the efficacy of intravitreal aflibercept injection on visual acuity in patients with symptomatic macular PCV.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Department of Medical Services Ministry of Public Health of Thailand trials

Trials by the same sponsor.

NCT06665737 — Outcomes of Early and Late Administration G-CSF for Primary Prophylaxis in Non-Hodgkin's Lymphoma Patients · Phase 4 · not yet recruiting
NCT06763575 — Efficacy of Surgical Glove-Compression Therapy As a Prevention of Paclitaxel-Induced Peripheral Neuropathy · NA · recruiting
NCT06860659 — Efficacy of 0.28% Sodium Hyaluronate Eye Drops in Patient With Moderate to Severe Dry Eye · Phase 4 · enrolling by invitation
NCT06525870 — Efficacy of Topical 85% TCA in the Treatment of LSIL After Low-grade Abnormality of Screening Test: a Randomized Control · Phase 2 · enrolling by invitation
NCT06436833 — Comparison of Bowel Preparation Using 2 Liter Polyethylene Glycol Regimen Plus Elobixibat Versus 4-Liter Polyethylene Gl · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02860858 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Department of Medical Services Ministry of Public Health of Thailand
Last refreshed: 23 October 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02860858.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing